https://pharmadog.xyz/news/676627 pharmadog en 2026-11-13T14:59:54.000Z Opinion: New organ donation rules are unfair to families https://pharmadog.xyz/news/676628 pharmadog en 2026-11-13T14:40:32.000Z Brain implant startup pauses trials https://pharmadog.xyz/news/676755 pharmadog en 2026-11-13T14:36:00.000Z Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties https://pharmadog.xyz/news/676629 pharmadog en 2026-11-13T14:33:16.000Z STAT+: Pharmalittle: We’re reading about Lilly conflict questions, a DEA OK for a narcolepsy pill, and more https://pharmadog.xyz/news/676459 pharmadog en 2026-11-13T14:00:00.000Z Senators propose bill to limit conflicts of interest on preventive services task force https://pharmadog.xyz/news/676647 pharmadog en 2026-11-13T14:00:00.000Z This week in charts: Brain drugs are back on venture capitalists’ minds https://pharmadog.xyz/news/676607 pharmadog en 2026-11-13T13:59:44.000Z Regeneron’s POTS antibody curbs heart rate spikes, teeing up Phase 3 trial https://pharmadog.xyz/news/676460 pharmadog en 2026-11-13T13:34:45.000Z Setbacks in two heart disease trials raise questions about future cardiovascular drug research https://pharmadog.xyz/news/676439 pharmadog en 2026-11-13T13:15:31.000Z ObesityWeek 2026 to showcase amylin pathway and emerging weight-loss mechanisms https://pharmadog.xyz/news/676247 pharmadog en 2026-11-13T12:00:11.000Z Gubra appoints ex-HHS official Brett Giroir as co-CEO after sudden exit of Markus Rohrwild https://pharmadog.xyz/news/676666 pharmadog en 2026-11-13T09:58:00.000Z The promise of molecular gates and what comes next https://pharmadog.xyz/news/676558 pharmadog en 2026-11-13T09:34:00.000Z Rezolute gets an uplift from phase 3 tumor hyperinsulinism win ahead of FDA meeting https://pharmadog.xyz/news/675789 pharmadog en 2026-11-13T09:30:00.000Z Investigation reveals U.S. fertility clinics offering unproven three-parent IVF to older women despite safety concerns https://pharmadog.xyz/news/675787 pharmadog en 2026-11-13T09:30:00.000Z Senator-elect Abdul El-Sayed vows to rebuild trust in science amid rising measles and other health threats https://pharmadog.xyz/news/675791 pharmadog en 2026-11-13T09:30:00.000Z Local schools launch experiments to curb teen phone addiction https://pharmadog.xyz/news/675790 pharmadog en 2026-11-13T09:30:00.000Z New Alzheimer’s biomarker tests raise existential concerns for people without symptoms https://pharmadog.xyz/news/675788 pharmadog en 2026-11-13T09:30:00.000Z Oura to acquire telehealth firm Counsel Health, raising conflict-of-interest concerns for Eli Lilly https://pharmadog.xyz/news/675550 pharmadog en 2026-11-13T03:55:00.000Z Virtuoso Surgical receives FDA De Novo clearance for robotic bladder lesion removal system https://pharmadog.xyz/news/676222 pharmadog en 2026-11-13T03:51:00.000Z Windward Bio raises $225 million in IPO to fund Chinese-sourced respiratory drug program https://pharmadog.xyz/news/676559 pharmadog en 2026-11-13T03:41:00.000Z Cellectis will shed 70% of workforce as part of in vivo pivot https://pharmadog.xyz/news/675719 pharmadog en 2026-11-13T03:31:00.000Z Regeneron posts positive phase 2 data for baloncibart in nervous system disorder, eyes pivotal trial https://pharmadog.xyz/news/674355 pharmadog en 2026-11-13T01:22:00.000Z Swiss biotech Windward Bio raises $175 million in IPO to fund lung-drug development and test Tezspire competitor https://pharmadog.xyz/news/673535 pharmadog en 2026-11-12T21:54:21.000Z Webinar Highlights Benefits of Cryopreserved Cells for Faster, Consistent CAR-T Manufacturing https://pharmadog.xyz/news/673343 pharmadog en 2026-11-12T20:09:22.000Z HHS rolls out new funding and research programs for psychedelics, with a focus on ibogaine https://pharmadog.xyz/news/673175 pharmadog en 2026-11-12T19:52:42.000Z Rezera delays $200M IPO amid weak market conditions https://pharmadog.xyz/news/673176 pharmadog en 2026-11-12T19:39:53.000Z Google launches Gemini AI platform for healthcare https://pharmadog.xyz/news/673177 pharmadog en 2026-11-12T19:34:07.000Z FDA’s fast-track voucher program appears to be discontinued, report finds https://pharmadog.xyz/news/673199 pharmadog en 2026-11-12T19:01:36.000Z Eli Lilly’s Mounjaro and Merck’s oral PCSK9 inhibitor win FDA nod amid string of cardiovascular trial setbacks https://pharmadog.xyz/news/673022 pharmadog en 2026-11-12T16:37:00.000Z Game Changer Products recalls 10 Day Forecast capsules after FDA finds undeclared sildenafil and acetaminophen https://pharmadog.xyz/news/672627 pharmadog en 2026-11-12T16:31:10.000Z STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment https://pharmadog.xyz/news/672706 pharmadog en 2026-11-12T16:25:00.000Z Eros Apothecary recalls Candy Power For Man honey supplement after undisclosed tadalafil found https://pharmadog.xyz/news/672583 pharmadog en 2026-11-12T16:15:42.000Z EnGene reports improved bladder cancer data after May setback https://pharmadog.xyz/news/672607 pharmadog en 2026-11-12T16:13:50.000Z Neurosterix raises $105M Series B to advance oral M4 schizophrenia drug and adds former Karuna leaders https://pharmadog.xyz/news/672584 pharmadog en 2026-11-12T16:03:16.000Z BioNTech spends $205 million to buy Scholar Rock’s FDA priority-review voucher as J&J scales back in Norway https://pharmadog.xyz/news/672648 pharmadog en 2026-11-12T16:03:00.000Z Bristol Myers appoints Cristian Massacesi as head of R&D as Robert Plenge exits https://pharmadog.xyz/news/672628 pharmadog en 2026-11-12T16:00:00.000Z Scientists release detailed basal ganglia cell map, uncover new neuron linked to schizophrenia https://pharmadog.xyz/news/672439 pharmadog en 2026-11-12T15:52:15.000Z FDA shelves Commissioner’s National Priority Voucher program ahead of Heidi Overton confirmation vote https://pharmadog.xyz/news/672459 pharmadog en 2026-11-12T15:38:37.000Z Senate debate looms over Heidi Overton’s potential FDA nomination https://pharmadog.xyz/news/134233 pharmadog en 2026-11-12T15:28:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/672415 pharmadog en 2026-11-12T15:06:12.000Z Merck KGaA records €366 million impairment on Lonza CDMO sale as PharmaLogic acquires Lantheus' manufacturing unit https://pharmadog.xyz/news/676390 pharmadog en 2026-11-12T15:05:00.000Z Bristol Myers Squibb reshuffles R&D leadership as chief research officer departs and CMO takes over combined unit https://pharmadog.xyz/news/672291 pharmadog en 2026-11-12T14:49:02.000Z New documents spark fresh concerns over Medicare's AI prior-authorization pilot https://pharmadog.xyz/news/672311 pharmadog en 2026-11-12T14:38:00.000Z FDA faces over 1,000 vacant positions as staffing shortage strains pharma oversight https://pharmadog.xyz/news/672292 pharmadog en 2026-11-12T14:14:55.000Z FDA shelves fast-track drug review program launched in 2025 https://pharmadog.xyz/news/672247 pharmadog en 2026-11-12T14:00:54.000Z Parker Institute chief urges renewed focus on cancer immunotherapy after mixed results from Revolution Medicines' drug https://pharmadog.xyz/news/672271 pharmadog en 2026-11-12T13:55:43.000Z Pfizer secures up to $1.5 billion from Blackstone to fund berobenatide obesity drug development https://pharmadog.xyz/news/672103 pharmadog en 2026-11-12T13:38:39.000Z BMS to consolidate R&D under single leader as chief research officer exits https://pharmadog.xyz/news/673318 pharmadog en 2026-11-12T13:34:00.000Z ARPA-H bets $4.9 million on ibogaine for PTSD treatment in veterans https://pharmadog.xyz/news/671911 pharmadog en 2026-11-12T12:29:08.000Z Bristol Myers shifts R&D leadership to chief medical officer Cristian Massacesi as research head Robert Plenge departs https://pharmadog.xyz/news/671935 pharmadog en 2026-11-12T12:26:32.000Z Experts say predictive analytics and distributed manufacturing could curb drug shortages https://pharmadog.xyz/news/671956 pharmadog en 2026-11-12T12:00:00.000Z American Cancer Society recommends routine PSA screening for men 50-69, strengthens guidance for high-risk groups https://pharmadog.xyz/news/671787 pharmadog en 2026-11-12T11:30:00.000Z Alnylam faces slowdown in Amvuttra sales, putting its growth ambitions at risk https://pharmadog.xyz/news/671788 pharmadog en 2026-11-12T11:30:00.000Z Biogen prepares to unveil results of litifilimab Phase 3 TOPAZ-1 and TOPAZ-2 lupus trials in December https://pharmadog.xyz/news/671635 pharmadog en 2026-11-12T11:17:18.000Z Blackstone pledges up to $1.5 billion to fund Pfizer's obesity drug berobenatide development https://pharmadog.xyz/news/672558 pharmadog en 2026-11-12T11:04:00.000Z FDA suspends National Priority Voucher pilot and pauses release of complete response letters https://pharmadog.xyz/news/672390 pharmadog en 2026-11-12T10:06:00.000Z Vor Bio pays RemeGen $10 million for rights to long-acting autoimmune drug candidate RC298 https://pharmadog.xyz/news/671345 pharmadog en 2026-11-12T09:30:00.000Z Newly elected doctors and scientists aim to rebuild public trust in science after midterm wins https://pharmadog.xyz/news/671343 pharmadog en 2026-11-12T09:30:00.000Z New governors should prioritize health hires, vaccination data, and a focused agenda https://pharmadog.xyz/news/671344 pharmadog en 2026-11-12T09:30:00.000Z Study finds Black Americans share many concerns with MAHA despite low overall support https://pharmadog.xyz/news/672391 pharmadog en 2026-11-12T09:28:00.000Z Kyverna pauses development of next-gen autoimmune CAR-T KYV-102 to focus on neurologic miv-cel program https://pharmadog.xyz/news/672054 pharmadog en 2026-11-12T08:16:00.000Z BMS consolidates R&D under chief medical officer Cristian Massacesi as chief research officer Robert Plenge exits https://pharmadog.xyz/news/670820 pharmadog en 2026-11-12T06:01:00.000Z Biopharma job postings rise 31% YoY in Q3 while layoffs plunge 90% https://pharmadog.xyz/news/670819 pharmadog en 2026-11-12T06:01:00.000Z Biopharma layoffs rise YoY in October but overall trend points down for 2026 https://pharmadog.xyz/news/670651 pharmadog en 2026-11-12T05:00:00.000Z Biopharma hiring surge in New Jersey as BioSpace lists ~300 open positions across 10 companies https://pharmadog.xyz/news/671275 pharmadog en 2026-11-12T03:57:00.000Z Neurosterix secures $105M Series B to launch phase 2 schizophrenia trial https://pharmadog.xyz/news/671274 pharmadog en 2026-11-12T03:35:00.000Z Pfizer taps Blackstone for up to $1.5B to pave path to GLP-1's obesity launch https://pharmadog.xyz/news/673923 pharmadog en 2026-11-12T00:00:00.000Z EMA seeks industry input on draft guideline for biomarker-guided therapy approvals https://pharmadog.xyz/news/673922 pharmadog en 2026-11-12T00:00:00.000Z Specialized AI tools could streamline medical device regulatory work, experts say, but need expert oversight https://pharmadog.xyz/news/673921 pharmadog en 2026-11-12T00:00:00.000Z FDA asks industry for feedback on improving patient-level real-world data submissions https://pharmadog.xyz/news/673924 pharmadog en 2026-11-12T00:00:00.000Z FDA pauses voucher program as Eli Lilly's GLP-1 weight-loss drug cleared in China; experts see AI aid for device regulation https://pharmadog.xyz/news/669111 pharmadog en 2026-11-11T21:37:27.000Z Study of 100,000 diverse Americans uncovers thousands of new drug-response genetic variants https://pharmadog.xyz/news/672392 pharmadog en 2026-11-11T21:13:00.000Z Dual targeting of GPCRs and mutated Gαq/11 shows promise for uveal melanoma https://pharmadog.xyz/news/669067 pharmadog en 2026-11-11T21:00:55.000Z Neurosterix raises $105 million Series B to advance schizophrenia candidate https://pharmadog.xyz/news/668899 pharmadog en 2026-11-11T20:20:26.000Z Hims & Hers pivots to branded GLP-1 drugs after striking deal with Eli Lilly https://pharmadog.xyz/news/668775 pharmadog en 2026-11-11T19:44:07.000Z U.S. 'most-favored nations' policy prompts drugmakers to reconsider overseas launches https://pharmadog.xyz/news/668439 pharmadog en 2026-11-11T17:47:53.000Z MAHA backs convicted rapist Russell Brand, highlighting toxic culture within movement https://pharmadog.xyz/news/668251 pharmadog en 2026-11-11T16:20:46.000Z FDA issues warning letters to two Chinese API makers for refusing record requests https://pharmadog.xyz/news/668291 pharmadog en 2026-11-11T16:11:00.000Z Study warns German drug price hikes could raise US Medicaid spending by $300 million https://pharmadog.xyz/news/668103 pharmadog en 2026-11-11T16:00:00.000Z Study proposes new obesity metric that could reverse diagnoses for millions, aiming for more precise care https://pharmadog.xyz/news/668059 pharmadog en 2026-11-11T15:44:23.000Z Flagship Pioneering combines Valo Health and Montai Therapeutics into a single company